Bloino, J
Telehealth convenience is valuable, but continuity of careincluding periodic metabolic labs and dose adjustment guidanceultimately determines treatment success and safety
Monday Poster Session Category: Small Intestine P4045 - Comparative Risk of Small Intestinal Bacterial Overgrowth (SIBO) Among Patients Using GLP-1 Receptor Agonists: A Real-World Analysis Using TriNetX Monday, October 27, 2025 10:30 AM - 4:00 PM PDT Location: Exhibit Hall Has Audio Presenting Author(s) Lina AlQirem, MD 1 , Suria Devarapalli, DO 1 , Adalberto Guzman, MD 2 , Murad Qirem, MD 3 , Meer A
It has a nasty trait of taking its sweet time to come down naturally
Talk to a provider about Ozempic in as little as 24 hours* If youre considering Ozempic for weight loss, find a licensed weight-loss provider on Klarity Health